Table 1 Baseline patient characteristics according to presence or absence of late gadolinium enhancement on cardiac MRI

Age (years)

57 ± 12

53 ± 13

Male sex n (%)

38 (69)

59 (57)

BMI

28 ± 4

27 ± 4

eGFR (ml/min/1.73m²)

54 ± 15

52 ± 16

KDIGO stage n (%)

 2 (eGFR 60–89 ml/min/1.73m²)

22 (40)

32 (31)

 3a (eGFR 45–59 ml/min/1.73m²)

17 (30)

35 (33)

 3b (eGFR 30–44 ml/min/1.73m²)

14 (26)

29 (28)

 4 (eGFR 15–29 ml/min/1.73m²)

2 (4)

8 (8)

Aetiology n (%)

 Vasculitis

7 (13)

9 (9)

 GN

15 (27)

49 (47)

 Hereditary

10 (18)

13 (12)

 Systemic

8 (14)

9 (8)

 Infective

2 (4)

4 (4)

 Obstruction

4 (7)

3 (3)

 Hypertensive

1 (2)

5 (5)

 Interstitial

0 (0)

6 (6)

 Vascular

1 (2)

1 (1)

 Unknown

7 (13)

5 (5)

Systolic BP (mmHg)

128 ± 17

126 ± 14

Diastolic BP (mmHg)

78 ± 11

77 ± 10

Haemoglobin (g/L)

138 ± 14

132 ± 22

Total cholesterol (mg/dL)

90 ± 18

90 ± 18

NTproBNP (pg/mL)

55 [34–93]

59 [17–161]

Immunosuppression usage n (%)

16 (29)

22 (21)

Anti-hypertensive usage n (%)

45 (82)

83 (80)

Statin usage n (%)

24 (46)

39 (37)

 Q waves

3 (5)

4 (4)

 T inversion

5 (9)

12 (11)